Furthermore, CXCR4 silencing in HBEC-KRASV12high recipient cells completely prevented the increase of CD133+ and CD133+CXCR4+ subsets caused by COPD-EVs (Fig. 5B). This evidence concerns the gene CXCR4 and chronic obstructive pulmonary disease.